327 related articles for article (PubMed ID: 24582912)
1. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.
Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H
Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912
[TBL] [Abstract][Full Text] [Related]
2. Association between Blood 25-Hydroxyvitamin D Levels and Survival in Colorectal Cancer Patients: An Updated Systematic Review and Meta-Analysis.
Maalmi H; Walter V; Jansen L; Boakye D; Schöttker B; Hoffmeister M; Brenner H
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30011816
[TBL] [Abstract][Full Text] [Related]
3. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies.
Ma Y; Zhang P; Wang F; Yang J; Liu Z; Qin H
J Clin Oncol; 2011 Oct; 29(28):3775-82. PubMed ID: 21876081
[TBL] [Abstract][Full Text] [Related]
4. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
5. Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.
Hu K; Callen DF; Li J; Zheng H
Integr Cancer Ther; 2018 Jun; 17(2):217-225. PubMed ID: 28589744
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.
Gandini S; Boniol M; Haukka J; Byrnes G; Cox B; Sneyd MJ; Mullie P; Autier P
Int J Cancer; 2011 Mar; 128(6):1414-24. PubMed ID: 20473927
[TBL] [Abstract][Full Text] [Related]
7. Dose-response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: A meta-analysis.
Garland CF; Gorham ED
J Steroid Biochem Mol Biol; 2017 Apr; 168():1-8. PubMed ID: 27993551
[TBL] [Abstract][Full Text] [Related]
8. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
9. Could vitamin D sufficiency improve the survival of colorectal cancer patients?
Mohr SB; Gorham ED; Kim J; Hofflich H; Cuomo RE; Garland CF
J Steroid Biochem Mol Biol; 2015 Apr; 148():239-44. PubMed ID: 25533386
[TBL] [Abstract][Full Text] [Related]
10. 25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies.
Ekmekcioglu C; Haluza D; Kundi M
Int J Environ Res Public Health; 2017 Jan; 14(2):. PubMed ID: 28134804
[TBL] [Abstract][Full Text] [Related]
11. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
12. Low circulating 25-hydroxyvitamin D level is associated with increased colorectal cancer mortality: a systematic review and dose-response meta-analysis.
Wu G; Xue M; Zhao Y; Han Y; Zhang S; Zhang J; Li C; Xu J
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32686830
[TBL] [Abstract][Full Text] [Related]
13. Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).
Yuan C; Sato K; Hollis BW; Zhang S; Niedzwiecki D; Ou FS; Chang IW; O'Neil BH; Innocenti F; Lenz HJ; Blanke CD; Goldberg RM; Venook AP; Mayer RJ; Fuchs CS; Meyerhardt JA; Ng K
Clin Cancer Res; 2019 Dec; 25(24):7497-7505. PubMed ID: 31548349
[TBL] [Abstract][Full Text] [Related]
14. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
[TBL] [Abstract][Full Text] [Related]
16. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis.
Kim Y; Je Y
Br J Cancer; 2014 May; 110(11):2772-84. PubMed ID: 24714744
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer.
Ng K; Wolpin BM; Meyerhardt JA; Wu K; Chan AT; Hollis BW; Giovannucci EL; Stampfer MJ; Willett WC; Fuchs CS
Br J Cancer; 2009 Sep; 101(6):916-23. PubMed ID: 19690551
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: serum vitamin D and breast cancer risk.
Yin L; Grandi N; Raum E; Haug U; Arndt V; Brenner H
Eur J Cancer; 2010 Aug; 46(12):2196-205. PubMed ID: 20456946
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer.
Mohr SB; Gorham ED; Kim J; Hofflich H; Garland CF
Anticancer Res; 2014 Mar; 34(3):1163-6. PubMed ID: 24596354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
